2018-03-16
Added · Updated
The Hong Kong Monetary Authority issues this annex to define capital treatments for Authorized Institutions holding exposures covered by HKMC guarantee and insurance programs following the transfer of general insurance business. The document specifies distinct reporting and risk-weighting requirements under the Standardized, Basic, and Internal Ratings-Based approaches, primarily treating insured portions as deemed exposures to the HKMC. It mandates that references to the former HKMC be construed as HKMCI and maintains existing reporting arrangements to ensure data comparability and avoid undue reporting burdens during this transitional period.
1 Annex 1: Capital treatments for exposures covered by the Programmes after the transfer of the GI business
2 Programmes Capital treatments Return of Capital Adequacy Ratio (MA(BS)3) (ii) the CRM effect of the HKMC guarantee on the deemed exposure will be reflected in the Return by reporting the credit protection covered portion of the deemed exposure in the column “Principal Amount after CRM” under Class II item 4 (Domestic PSEs) and in the row for the risk-weight applicable to the HKMC; and (iii) the portion of the loan that is not covered by the HKMCI’s insurance or guarantee, if any, will be reported in the column “Principal Amount after CRM” under the exposure class to which the loan belongs. (Note: Recognizing that the capital treatments, which are transitional in nature, will affect only about 3 position dates (end-June, end-September and end-December) and there is essentially no change in the credit risk to which AIs are exposed, the HKMA is inclined to keep the reporting arrangements unchanged in order to preserve comparability of data across different position dates and to avoid distortion of the risk
3 Programmes Capital treatments Return of Capital Adequacy Ratio (MA(BS)3) profile of an AI’s credit portfolio due to significant changes in the amounts reported in certain exposure classes (e.g. Class VI (Corporate Exposures) and Class X (Residential Mortgage Loans))). 5. 80% Guarantee Scheme supported by the Government’s commitment The capital treatments and the conditions set out in the circular of 27 June 2012 continue to apply. However, the references to “HKMC” should be construed as references to “HKMCI” and, to reflect the current drafting of the Banking (Capital) Rules, the reference to “subsections 100(9)(c) to (f)” should be construed as a reference to subsections 100(9)(a) to (d) and the reference to “subsection 100(9)(f)” should be construed as a reference to subsection 100(9)(d). No adjustment to the reporting arrangement is required. 2. The BSC approach Programmes Capital treatments Return of Capital Adequacy Ratio (MA(BS)3)
4 Programmes Capital treatments Return of Capital Adequacy Ratio (MA(BS)3) 2. Reverse Mortgage Programme 3. Premium Loan Insurance Scheme 4. SME Financing Guarantee Scheme (other than the 80% Guarantee Scheme supported by the Government’s commitment) (i) since the deemed exposure will be fully covered by the HKMC guarantee, the credit protection uncovered portion of the deemed exposure should be zero. The credit protection covered portion of the deemed exposure will be reported in the column “Principal Amount” under Class II item 13 (Exposures to PSEs of Tier 1 countries); and (ii) the portion of the loan that is not covered by the HKMCI’s insurance or guarantee, if any, will be reported in the column “Principal Amount” under the exposure class to which the loan belongs. 5. 80% Guarantee Product supported by the Government’s commitment The capital treatments and the conditions set out in the circular of 27 June 2012 apply to AIs using the BSC approach as they apply to AIs using the STC approach. However, the references to “HKMC” should be construed as references to “HKMCI”, the reference to “subsections 100(9)(c) to (f)” should be construed as a reference to subsections 134(6)(a) to (d) and the reference to “subsection 100(9)(f)” should be construed as a reference No adjustment to the reporting arrangement is required.
5 Programmes Capital treatments Return of Capital Adequacy Ratio (MA(BS)3) to subsection 134(6)(d). 3. The IRB approach Programmes1 Capital treatments Return of Capital Adequacy Ratio (MA(BS)3)
1 As stated in the HKMA circular of 17 June 2011, AIs are not allowed to use the IRB approach for their RMLs exposures under the HKMC’s Reverse Mortgage Programme.
6 Programmes1 Capital treatments Return of Capital Adequacy Ratio (MA(BS)3) commitment However, the references to “HKMC” should be construed as references to “HKMCI”; the references to “section 100(9)” should be construed as references to section 216(3A) or 217(4), as the case requires; the reference to “subsections 100(9)(c) to (f)” should be construed as a reference to subsections 216(3A)(a) to (d) or 217(4)(a) to (d), as the case requires; and the reference to “subsection 100(9)(f)” should be construed as a reference to subsection 216(3A)(d) or 217(4)(d), as the case requires.